Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DGX | Diploma ball in Di Latte court | 10/02/19 | 0 | 5.7K | |||
|
|||||||
DGX | Ann: Removal from Official List - Annual Listing Fees | 29/08/18 | 0 | 910 | |||
|
|||||||
DGX | Ann: Suspension from Official Quotation - Annual Listing Fees | 22/08/18 | 0 | 756 | |||
|
|||||||
DGX | Ann: Suspension Announcement - System Upgrade | 06/08/18 | 0 | 907 | |||
|
|||||||
DGX | Ann: Suspension Announcement - System Upgrade | 06/08/18 | 0 | 475 | |||
|
|||||||
DGX | Ann: Appointment of Liquidators | 01/03/18 | 1 | 1.9K | |||
|
|||||||
DGX | Ann: Suspension from Official Quotation - Annual Listing Fees | 22/08/17 | 0 | 959 | |||
|
|||||||
DGX | DiLatte's Accused of Siphoning Millions | 01/06/17 | 4 | 13K | |||
|
See All Discussions